Home / Stocks / LXRX

LXRX insider trading

LEXICON PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$2.7M
Buys · last 90 days
0 · $0
Most recent buy
2026-02-27

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-02-27DEBBANE RAYMOND
Director
Bought2,000$1.49$3k
2026-02-25DEBBANE RAYMOND
Director
Bought100,000$1.47$147k
2026-02-23DEBBANE RAYMOND
Director
Bought150,000$1.47$220k
2026-02-18DEBBANE RAYMOND
Director
Bought268,497$1.31$353k
2026-02-04Artal Group S.A.
Director · 10% owner
Bought1,538,462$1.30$2.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Artal Group S.A.Director · 10% owner1$2.0M
DEBBANE RAYMONDDirector4$723k

See LXRX on the chart

Every insider buy and sell for LXRX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.